Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration

Low-molecular-weight heparin (LMWH) is an anticoagulant used to prevent clotting during blood purification treatments. This study aimed to evaluate the clinical use of the anti-factor Xa level (anti-Xa) for monitoring LMWH anticoagulant levels during intermittent venovenous hemofiltration (IVVHF). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Lengnan, Sun, Ying, Wang, Songlan, Li, Chuanbao, Mao, Yonghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344977/
https://www.ncbi.nlm.nih.gov/pubmed/37395763
http://dx.doi.org/10.1007/s00277-023-05290-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344977/
https://www.ncbi.nlm.nih.gov/pubmed/37395763
http://dx.doi.org/10.1007/s00277-023-05290-7

Ejemplares similares